L10p and P158DEL DJ-1 mutations cause protein instability, aggregation, and dimerization impairments.
A variety of mutations in the gene encoding DJ-1 protein cause autosomal recessive early-onset parkinsonism. Recently, a novel pathogenic homozygous DJ-1 missense mutation resulting in the L10P amino acid substitution was reported. In a separate study, a novel homozygous mutation resulting in the deletion of DJ-1 residue P158 was also reported to be causative of disease. The specific effects of the novel L10P and P158DEL mutations on protein function have not been studied. Here, L10P and P158DEL DJ-1 proteins were assessed for protein stability, dimerization, solubility, subcellular localization, and protective function in comparison with WT and the L166P DJ-1 pathogenic variant. It was discovered that, compared with WT protein, L10P, L166P, and P158DEL DJ-1 variants exhibited dramatically reduced protein stabilities. Degradation of each of the pathogenic mutants appeared to be mediated in part by the proteasome. Interestingly, unlike L166P DJ-1, the L10P and P158DEL DJ-1 variants retained the ability to dimerize with WT DJ-1 protein; however, neither of these mutants was able to form homodimers. Additionally, the L10P, L166P, and P158DEL DJ-1 variants exhibited altered profiles on size-exclusion chromatography and demonstrated reduced solubilities in comparison with WT protein, and the latter aberration could be exacerbated in the presence of MG-132. Furthermore, cells stably expressing L10P DJ-1 were more vulnerable to treatments with proteasome inhibitors, suggesting that L10P DJ-1 may be toxic to cells under conditions of proteasome stress. Taken together, these findings suggest that diverse aberrant mechanisms, including alterations in protein stability and protein folding, are associated with the pathogenicity of the L10P and P158DEL DJ-1 variants.
Ramsey
Chenere P
CP
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6084, USA.
Giasson
Benoit I
BI
D000818:Animals; D016466:CHO Cells; D002470:Cell Survival / Q000235:genetics; D006224:Cricetinae; D003412:Cricetulus; D006801:Humans; D002479:Inclusion Bodies / Q000235:genetics / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics*; D009154:Mutation / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D010300:Parkinson Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D000071617:Protein Deglycase DJ-1; D017510:Protein Folding; D055503:Protein Multimerization; D055550:Protein Stability; D012995:Solubility
D047908:Intracellular Signaling Peptides and Proteins; D015513:Oncogene Proteins; C105131:PARK7 protein, human; D000071617:Protein Deglycase DJ-1
Hum Mol Genet. 2005 Jan 1;14(1):71-84
15525661
Cell Death Differ. 2010 Jan;17(1):158-69
19680261
Annu Rev Genomics Hum Genet. 2006;7:103-24
16722804
Brain Res. 2008 Nov 6;1239:1-11
18822273
J Biol Chem. 2007 May 4;282(18):13680-91
17331951
Free Radic Biol Med. 2009 Nov 15;47(10):1354-61
19686841
Biochim Biophys Acta. 2009 Jul;1792(7):587-96
19168133
FEBS Lett. 2003 Aug 14;549(1-3):171-5
12914946
Neurobiol Aging. 2006 Apr;27(4):530-45
16207501
Acta Crystallogr D Biol Crystallogr. 2003 Aug;59(Pt 8):1502-3
12876366
Ann Neurol. 2004 Jan;55(1):113-8
14705119
Mol Cell Neurosci. 2004 Nov;27(3):236-46
15519239
Science. 2003 Jan 10;299(5604):256-9
12446870
BMC Evol Biol. 2004 Feb 19;4:6
15070401
Hum Mol Genet. 2009 Apr 15;18(R1):R48-59
19297401
Biochem Biophys Res Commun. 1997 Feb 13;231(2):509-13
9070310
Acta Neuropathol. 2004 Jun;107(6):489-96
14991385
Biochem Biophys Res Commun. 2003 Dec 26;312(4):1342-8
14652021
FEBS J. 2008 Dec;275(23):5758-66
19021753
Mol Reprod Dev. 2004 Jul;68(3):373-83
15112332
J Biol Chem. 2004 Feb 27;279(9):8506-15
14665635
Neurobiol Dis. 2007 Oct;28(1):122-32
17719794
Mov Disord. 2006 Nov;21(11):1806-23
16972273
Hum Mol Genet. 2003 Nov 1;12(21):2807-16
12952867
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9256-61
12855764
Mov Disord. 2008 Oct 30;23(14):2074-9
18785233
Biochemistry. 2008 Sep 9;47(36):9380-93
18707128
J Med Genet. 2004 Mar;41(3):e22
14985393
J Biol Chem. 2004 Feb 20;279(8):6943-51
14607841
J Biol Chem. 2003 Sep 19;278(38):36588-95
12851414
J Neurochem. 2003 Dec;87(6):1558-67
14713311
J Cell Biol. 2007 Sep 10;178(6):1025-38
17846173
J Neurochem. 2005 Jun;93(6):1524-32
15935068
Arch Neurol. 2008 Feb;65(2):184-9
18268186
Cell Death Differ. 2006 Jan;13(1):96-108
15976810
Mov Disord. 2009 Jan 30;24(2):196-203
18973254
Brain Res Mol Brain Res. 2005 Mar 24;134(1):76-83
15790532
Biochem Biophys Res Commun. 2004 Jul 23;320(2):389-97
15219840